Finally, in 39 patients with carcinoma of the tongue treated with surgery, Tanaka et al. [17] found that immunopositivity to PIM-1 correlated with regional and distant recurrences along with a decrease in survival. The gene discussed is PIM1; the disease is tongue cancer.